ENANTA PHARMACEUTICALS INC Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Enanta Pharmaceuticals Inc Return On Assets for the quarter ending June 30, 2024 was -27.1 %, a 20.8% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2023 was -32.8 %, a 8.32% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2022 was -30.3 %, a 76.1% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2021 was -17.2 %, a 140% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -32.8 -2.52 -8.32% Oct 1, 2022 Sep 30, 2023
2022 -30.3 -13.1 -76.1% Sep 30, 2021 Sep 30, 2022
2021 -17.2 -10 -140% Oct 1, 2020 Sep 30, 2021
2020 -7.15 -17 -172% Oct 1, 2019 Sep 30, 2020
2019 9.87 -9.46 -48.9% Oct 1, 2018 Sep 30, 2019
2018 19.3 +13.2 +217% Oct 1, 2017 Sep 30, 2018
2017 6.11 -1.61 -20.9% Oct 1, 2016 Sep 30, 2017
2016 7.72 -25.7 -76.9% Oct 1, 2015 Sep 30, 2016
2015 33.4 +7.61 +29.5% Oct 1, 2014 Sep 30, 2015
2014 25.8 Oct 1, 2013 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.